Socioeconomic differences in obese patients with and without eating disorders

2007 ◽  
Vol 12 (4) ◽  
pp. e98-e103 ◽  
Author(s):  
H. Bergström ◽  
K. Elfhag
2021 ◽  
Vol 23 (5) ◽  
pp. 412-416
Author(s):  
Georgy L. Yurenev ◽  
◽  
Ekaterina M. Mironova ◽  
Natalia A. Sirota ◽  
Tamara V. Yureneva-Tkhorzhevskaya ◽  
...  

Background. Eating disorders, as well as features of the psychoemotional status as risk factors for obesity, patients with comorbid gastroesophageal reflux disease (GERD) and obesity in the modern literature are not sufficiently disclosed. Further study of these aspects may be one of the additional ways to improve the prognosis of the course of GERD, as well as the correction of the psychoemotional status of patients. Aim. To study the features of the course of GERD in concomitant obesity in the context of the peculiarities of the psychoemotional sphere, as well as to identify the types of eating disorders in this cohort of patients. Materials and methods. The study included 130 patients aged 24 to 72 years with complaints characteristic of the pathology of the upper digestive tract, who, along with a detailed analysis of complaints in order to verify the diagnosis and identify the features of the course of the disease, were tested with the Dutch Eating Behavior Questionnaire (DEBQ) and the hospital scale of anxiety and depression (HADS). Results. It was found that obese patients who had GERD less than 8 years ago were more likely to suffer from external and emotionogenic eating disorders, and the external type was more often associated with the male, and the emotionogenic type with the female sex. Whereas, in patients with obesity and a history of GERD for more than 8 years, the restrictive and emotionogenic types of eating disorders were relatively more often recorded. An increased level of anxiety in patients with GERD was noted, both against the background of obesity and without it, but those with comorbid pathology had a relatively higher score on the anxiety scale. Conclusion. Correction of eating behavior and signs of anxiety-depressive states in patients can open up new prospects for the fight against obesity. And this, in turn, can improve the prognosis of patients with GERD.


2013 ◽  
Vol 23 (12) ◽  
pp. 2075-2079 ◽  
Author(s):  
Alfredo Genco ◽  
Roberta Maselli ◽  
Francesca Frangella ◽  
Massimiliano Cipriano ◽  
Emanuela Paone ◽  
...  

2021 ◽  
Vol 9 (1) ◽  
Author(s):  
Mladena Simeunovic Ostojic ◽  
Joyce Maas ◽  
Nynke M. G. Bodde

AbstractSince COVID-19 is a global health emergency, there is an urgent need to share experiences on decision-making with regard to safety recommendations and for hypotheses that can inform a more focused prevention and treatment. Moreover, combining research into eating disorders and obesity with research into COVID-19 may provide a unique opportunity to shed light on the susceptibility to COVID-19.


Author(s):  
Margherita Barbuti ◽  
Giulio E. Brancati ◽  
Alba Calderone ◽  
Paola Fierabracci ◽  
Guido Salvetti ◽  
...  

Abstract Purpose We aimed at investigating the lifetime prevalence of mood, eating and panic disorders in a large sample of obese patients referred to bariatric surgery. We also explored the patterns of psychiatric comorbidity and their relationship with Body Mass Index (BMI). Methods The sample was composed of patients consecutively referred for pre-surgical evaluation to the Obesity Center of Pisa University Hospital between January 2004 and November 2016. Clinical charts were retrieved and examined to obtain sociodemographic information, anthropometric variables and lifetime psychiatric diagnoses according to DSM-IV criteria. Results A total of 871 patients were included in the study; 72% were females, and most patients had BMI ≥ 40 kg/m2 (81%). Overall, 55% of the patients were diagnosed with at least one lifetime psychiatric disorder. Binge eating disorder (27.6%), major depressive disorder (16%), bipolar disorder type 2 (15.5%), and panic disorder (16%) were the most common psychiatric diagnoses. Mood disorders showed associations with panic disorder (OR = 2.75, 95% CI = 1.90–3.99, χ2 = 41.85, p = 0.000) and eating disorders (OR = 2.17, 95% CI 1.64–2.88, χ2 = 55.54, p = 0.000). BMI was lower in patients with major depressive disorder (44.9 ± 7.89) than in subjects without mood disorders (46.75 ± 7.99, padj = 0.017). Conclusion Bariatric patients show high rates of psychiatric disorders, especially binge eating and mood disorders. Longitudinal studies are needed to explore the possible influence of such comorbidities on the long-term outcome after bariatric surgery. Level of evidence V, cross sectional descriptive study.


2020 ◽  
Vol 11 (1) ◽  
pp. 507-510
Author(s):  
Elham Alshammari ◽  
Ahlam Alshammari

The purpose of this study is to examine the effectiveness of topiramate in promoting weight loss among obese patients. The study was inspired by the fact that men and women, in addition to the stereotyped teenager, are affected by eating disorders. The general scope of this paper will comprise of the evaluation of the effectiveness of topiramate in weight loss amongst obese patients. The research achieves this through a review of past literature. In sum, the reviewed study found that the use of topiramate was associated with an increase in positive outcomes. Most of the positive outcomes were linked with weight reduction among overweight and obese patients. The review also revealed that the administration of the drug reduced the adverse effects of psychotic drugs minimized food cravings, alcohol, and smoking. Moreover, the combination of the drug with other antiepilepsy medications had more positive outcomes than when used as a monotherapy.


2020 ◽  
Vol 40 ◽  
pp. 441
Author(s):  
M. Arnal-Couderc ◽  
P. Fayemendy ◽  
B. Morin ◽  
G. Laroumagne ◽  
C. De Rouvray ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document